Provided by Tiger Fintech (Singapore) Pte. Ltd.

Gyre Therapeutics

8.40
-0.4800-5.41%
Post-market: 8.400.00000.00%16:05 EDT
Volume:161.06K
Turnover:1.40M
Market Cap:786.34M
PE:174.72
High:9.39
Open:8.72
Low:8.26
Close:8.88
Loading ...
Mar 21, 2024

Major Issues Report

Form 8-K - Current report
Mar 15, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 14, 2024

Major Issues Report

Form 8-K - Current report
Feb 14, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Jan 24, 2024

Beneficial Ownership Change

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
Jan 20, 2024

Major Issues Report

Form 8-K/A - Current report: [Amend]
Jan 13, 2024

Major Issues Report

Form 8-K/A - Current report: [Amend]
Dec 15, 2023

Major Issues Report

Form 8-K - Current report
Dec 07, 2023

Major Issues Report

Form 8-K - Current report
Nov 27, 2023

Beneficial Ownership Change

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
Nov 14, 2023

Major Issues Report

Form 8-K - Current report
Nov 13, 2023

Major Issues Report

Form 8-K - Current report
Nov 06, 2023

Major Issues Report

Form 8-K - Current report
Nov 02, 2023

Major Issues Report

Form 8-K - Current report
Nov 01, 2023

Beneficial Ownership Change

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
Oct 31, 2023

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Oct 31, 2023

Beneficial Ownership Change

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
Oct 30, 2023

Major Issues Report

Form 8-K - Current report
Oct 27, 2023

Major Issues Report

Form 8-K - Current report
Oct 25, 2023

Correspondence

Form CORRESP - Correspondence